Julia Beimdiek

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Embryonic Stem Cells

Simultaneous Determination

Top Venues

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Charlotte Rossdam, Smilla Brand, Julia Beimdiek, Astrid Oberbeck, Marco Darius Albers, Ortwin Naujok, Falk F R Büttner
Targeting the glycan epitope type I N-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells. Glycobiology (2024)
Charlotte Rossdam, Smilla Brand, Julia Beimdiek, Astrid Oberbeck, Marco Darius Albers, Ortwin Naujok, Falk F R Büttner
Targeting the glycan epitope type I N-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells. Glycobiology 34 (4) (2024)
Charlotte Rossdam, Smilla Brand, Julia Beimdiek, Astrid Oberbeck, Marco Darius Albers, Ortwin Naujok, Falk F R Büttner
Targeting the glycan epitope type I N-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells. Glycobiology 34 (4) (2024)
Henri Wedekind, Julia Beimdiek, Charlotte Rossdam, Elina Kats, Vanessa Wittek, Lisa Schumann, Inga Sörensen-Zender, Arno Fenske, Birgit Weinhold, Roland Schmitt, Andreas Tiede, Falk F R Büttner, Anja K Münster-Kühnel, Markus Abeln
The monosialoganglioside GM1a protects against complement attack. Cell death discovery 9 (1) (2023)